Tissue Regenix Group financials at a glance
| Year | Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
£0.00M | £0.00M | £0.00M | £0.00M | £0.00M | £0.00M | £1.57M | £5.23M | £11.62M | £13.03M | £12.83M | £19.75M | £24.48M | £0.00M | £0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 49.41% | 49.80% | 50.93% | 46.18% | 45.96% | 42.93% | 46.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -185.71% | -71.14% | -55.08% | -32.50% | -20.75% | -8.21% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
£-0.57 | £-0.55 | £-0.88 | £-1.19 | £-1.29 | £-0.90 | £-0.67 | £-0.66 | £-0.08 | £-0.05 | £-0.03 | £-0.01 | £0.00 | ||
| Div. | Dividends |
|
£0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
469.1m | 634.84m | 635.28m | 635.32m | 637.18m | 743.18m | 743.18m | 1154.05m | 1155.62m | 1155.86m | 7016.96m | 70.17m | 70.2m | 70.41m | 0m |
| OCF | Operating Cash Flow |
|
£0.00M | £0.00M | £0.00M | £0.00M | £0.00M | £0.00M | £-11.79M | £-9.79M | £-6.84M | £-6.68M | £-5.23M | £-2.98M | £-1.29M | £0.00M | £0.00M |
| FCF | Free Cash Flow |
|
£0.00M | £0.00M | £-2.16M | £0.00M | £0.00M | £0.00M | £-10.72M | £-9.87M | £-7.13M | £-7.12M | £-7.25M | £-4.38M | £-1.37M | £-1.61M | £0.00M |
| FCFS | Free Cash Flow Per Share |
|
£0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £-0.02 | £-0.01 | £-0.01 | £-0.01 | £-0.00 | £-0.00 | £-0.03 | £0.00 | £0.00 |